Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Surufatinib”

110 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 110 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05106777
What this trial is testing

Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Study completedNCT04169672
What this trial is testing

Study of Surufatinib Single Agent or Surufatinib Combined With Toripalimab in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Hutchison Medipharma Limited 248
Testing effectiveness (Phase 2)UnknownNCT05030246
What this trial is testing

Trial of Surufatinib Combined With Toripalimab in the Treatment of Peritoneal Metastatic Carcinoma of Gastrointestinal or Primary Peritoneal Cancer

Who this might be right for
Refractory Metastatic Digestive System CarcinomaPrimary Peritoneal Cancer
Peking University 72
Large-scale testing (Phase 3)Study completedNCT02588170
What this trial is testing

Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Hutchison Medipharma Limited 219
Testing effectiveness (Phase 2)Looking for participantsNCT07086456
What this trial is testing

Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
SurufatinibTislelizumabConcurrent Chemoradiotherapy+2 more
Sun Yat-sen University 80
Testing effectiveness (Phase 2)UnknownNCT05235906
What this trial is testing

A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer

Who this might be right for
Gastric Adenocarcinoma
Sun Yat-sen University 61
Not applicableUnknownNCT05064852
What this trial is testing

A Real-world Study of the Safety and Efficacy of Surufatinib in the Treatment of Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Carcinoma
Qilu Hospital of Shandong University 200
Testing effectiveness (Phase 2)Study completedNCT05509699
What this trial is testing

Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Hutchison Medipharma Limited 21
Not applicableNot Yet RecruitingNCT07780539
What this trial is testing

Real-World Study of the Safety and Efficacy of Surufatinib in the Treatment of Neuroendocrine Tumors

Who this might be right for
Neuroendocrine (NE) Tumors
Yefeng 60
Large-scale testing (Phase 3)Looking for participantsNCT06361888
What this trial is testing

A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Hutchmed 502
Testing effectiveness (Phase 2)Looking for participantsNCT05747729
What this trial is testing

A Single-arm, Open-label, Clinical Trial of Surufatinib/Serplulimab/Platinum/Etoposide in Neuroendocrine Carcinoma.

Who this might be right for
Neuroendocrine Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)Study completedNCT05908747
What this trial is testing

Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital 29
Testing effectiveness (Phase 2)UnknownNCT06375642
What this trial is testing

A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)Study completedNCT02267967
What this trial is testing

Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Hutchison Medipharma Limited 81
Early research (Phase 1)Study completedNCT04372407
What this trial is testing

Assess the Effect of a Strong CYP3A Inhibitor, on Surufatinib in Healthy Subjects

Who this might be right for
Healthy
Hutchison Medipharma Limited 13
Testing effectiveness (Phase 2)UnknownNCT04524884
What this trial is testing

Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study

Who this might be right for
Thyroid Cancer
Fudan University 10
Testing effectiveness (Phase 2)Temporarily pausedNCT06199882
What this trial is testing

SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Carcinoma
Zhejiang Cancer Hospital 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06531291
What this trial is testing

Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation

Who this might be right for
ESCCBiliary Tract CancerGastric Cancer+1 more
RenJi Hospital 80
Testing effectiveness (Phase 2)Study completedNCT02549937
What this trial is testing

A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors

Who this might be right for
Tumors
Hutchmed 130
Post-approval studies (Phase 4)Looking for participantsNCT07272512
What this trial is testing

Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms

Who this might be right for
Neuroendocrine TumorsNeuroendocrine Neoplasms
Shanghai Zhongshan Hospital 350
Next Page